Issue 77

bicycle day

Bicycle Day

On 19 April 1943, Albert Hofmann intentionally consumed LSD, marking the first recorded experience with the psychedelic medicine.

The hallucinations intensified on the bicycle ride from the laboratory, and the day was eternalised within the counterculture community as ‘bicycle day’.

Hofmann first synthesised LSD-25 in 1936 while researching stimulants and ergot’s impact on the cardiovascular system.

It wasn’t until seven years later, however, that he became aware of its psychoactive properties – through accidental exposure.

READ MORE

MINDMED TO PRESENT CLINICAL TRIAL RESULTS AT PSYCH SYMPOSIUM

Dr Holze and Professor Liechti from University of Basel will share data from the first study of LSD in over 40 years.

Read More

ARE PSYCHEDELIC STOCKS REACHING THE BOTTOM AS BAD INVESTORS BAIL?

atai Life Sciences’ Founder Christian Angermayer said overambitious investors were partly to blame.

Read More

BUSINESS AND INVESTMENT

Nue Life Health raises US$23 million in Series A funding round.

Silo Wellness announces financing commitment of C$5.95 million.

Numinus reports Q2 2022 financial results.

Awakn provides update on European psychedelic healthcare clinics.

Braxia Scientific reaches agreements to settle class actions.

Can old legal strategies thwart psychedelic monopolies?

Could psychedelic medicines be used to treat mental health disorders?

Mindset files patent for 5-MeO-DMT and DMT analogues.

PSYCH Symposium: London 2022

Tickets for the limited capacity event are selling fast. Register today to connect with decision makers and contribute to the future of psychedelic medicine in Europe.

Speakers include:

Alejandro Antalich – Biomind Labs

Benjamin Lightburn – Filament Health

Dr Rosalind Watts – ACER Integration

REGISTER YOUR TICKET

SCIENCE AND RESEARCH

Freedom to Operate publishes LSD research to hamper patent applications.

Psychedelic medicines could be a therapeutic breakthrough for addiction.

Brain imaging studies suggest how ketamine reduces PTSD symptoms.

Understanding the effects of MDMA on bipolar disorder.

REGULATION AND LEGISLATION

Colorado House passes bill to legalise MDMA following federal approval.

Massachusetts activists push for decriminalisation on November ballot.